The 2nd Durban Declaration draws attention to progress in the fight against HIV and work yet to do
New mouse models provide insights into how to design a more effective HIV vaccine
Do HIV-infected children who do not develop AIDS hold clues to a cure?
Preclinical evaluation of an mRNA HIV vaccine combining rationally selected antigenic sequences and adjuvant signals (HTI-TriMix)
Modulation of innate and adaptive cellular immunity relevant to HIV-1 vaccine design by seminal plasma
Removal of ribonucleotides by p53 protein incorporated during DNA synthesis by HIV-1 reverse transcriptase
Early age at start of antiretroviral therapy associated with better virologic control after initial suppression in HIV-infected infants
Sex differences in the association of HIV infection with hepatic steatosis
One-year mortality of HIV-positive patients treated for rifampicin- and isoniazid-susceptible tuberculosis in Eastern Europe, Western Europe, and Latin America
Higher CD163 levels are associated with insulin resistance in hepatitis C virus-infected and HIV-infected adults
Impact of HIV infection and antiretroviral treatment on N-terminal prohormone of brain natriuretic peptide as surrogate of myocardial function
Effects of depression and anxiety on antiretroviral therapy adherence among newly diagnosed HIV-infected Chinese MSM
HIV surveillance combining an assay for identification of very recent infection and phylogenetic analyses on dried spots
An epidemiological modelling study to estimate the composition of HIV-positive populations including migrants from endemic settings
Life expectancy in HIV-positive persons in Switzerland
Association of cognitive activity and neurocognitive function in blacks and whites with HIV
Interpreting the influence of race and cognitive activity on neurocognition in adults aging with HIV
A novel anti-HIV immunotherapy to cure HIV
HIV and hypogonadism
Discontinuation of treatment and adverse events in an Italian cohort of patients on dolutegravir
Efficacy and tolerability of dolutegravir and two nucleos(t)ide reverse transcriptase inhibitors in HIV-1-positive, virologically suppressed patients
We should monitor the population-level effects of preexposure prophylaxis